NLS Pharmaceutics Ltd. (NLSP)
NLS Pharmaceutics will go public soon, but the exact IPO date is still unknown.
Stock Price: $5.00 - $6.00
Current IPO price range
| Market Cap | 58.28M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.45M |
| Shares Out | 10.60M |
| EPS (ttm) | -0.51 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
News
There are no news available yet.
About NLSP
NLS Pharmaceutics is an innovative biotechnology company engaged in the discovery and development of life-improving drug therapies to treat rare and complex central nervous system, or CNS, disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder, or ADHD. CNS disorders are a diverse group of conditions that include neurological, psychiatric, and substance use disorders. According to the World Health Organization and based on data... [Read more...]
| CEO Alexander Zwyer | Employees 5 |
| Stock Exchange NASDAQ | Ticker Symbol NLSP |